Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19) (News)

The LDN 2021 Conference Recordings Now Available with up to 29 CME Credits [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Submitted by baileylynn_100964 on Fri, 02/12/2021 - 04:11

Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19)

LancasterOnline
14 Jan 2021
https://lancasteronline.com/news/health/halberd-corp-develops-medication-to-boost-immune-system-against-sars-cov-2-covid-19/article_78231771-5ffe-5bd0-87ec-a01a9d114ae9.html

Halberd Corp. filed a provisional patent application on a proprietary combination of nutritional supplements (melatonin, zinc and Vitamin D) combined with low dose Naltrexone designed to reduce the severity of Covid-19 symptoms.